Relationships between Cognitive Performance, Neuroimaging and Vascular Disease: The DHS-MIND Study

Neuroepidemiology

Volumn 45, Issue 1, 2015, Pages 1-11

  Hsu, Fang Chi ^a,b   Raffield, Laura M ^b,c,d   Hugenschmidt, Christina E ^e   Cox, Amanda ^b,d,i   Xu, Jianzhao ^b,d   Carr, J Jeffery ^h   Freedman, Barry I ^b,d,f   Maldjian, Joseph A ^g   Williamson, Jeff D ^e   Bowden, Donald W ^a,b,d  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b Center for Clinical Research   (United States)

^c Department of Internal Medicine   (United States)

^d Center for Human Genomics   (United States)

^e Section on Internal Medicine and Gerontology Bowman Gray   (United States)

^f Section on Nephrology   (United States)

^g Department of Radiology ^*  (United States)

^h VANDERBILT UNIVERSITY   (United States)

ⁱ GRIFFITH UNIVERSITY   (Australia)

Author keywords

Cognitive testing; Coronary artery calcified plaque; Neuroimaging; Type 2 diabetes; Vascular disease

Indexed keywords

ADULT; AGED; ARTICLE; ASSOCIATION; BRAIN SIZE; CARDIOVASCULAR RISK; COGNITION; CORONARY ARTERY CALCIFICATION; DIFFUSION TENSOR IMAGING; ECHO PLANAR IMAGING; FEMALE; FRACTIONAL ANISOTROPY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREVALENCE; RESPONSE TIME; STROOP TEST; VASCULAR DISEASE; VERBAL MEMORY; WHITE MATTER LESION; WORD LIST RECALL; WORKING MEMORY; BRAIN; COGNITION DISORDERS; COHORT ANALYSIS; DIABETES MELLITUS, TYPE 2; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PLAQUE, ATHEROSCLEROTIC; PSYCHOLOGY; RISK FACTOR; VASCULAR CALCIFICATION; VASCULAR DISEASES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN; COGNITION DISORDERS; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NEUROIMAGING; NEUROPSYCHOLOGICAL TESTS; PLAQUE, ATHEROSCLEROTIC; RISK FACTORS; VASCULAR CALCIFICATION; VASCULAR DISEASES;

EID: 84939570367     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000435775     Document Type: Article

References (51)

1. Reijmer Y, van den Berg E, Ruis C, Kappelle LJ, Biessels GJ: Cognitive dysfunction in patients with type 2 diabetes. Diabetes Metab Res Rev 2010; 26: 507-519.
2. van Harten B, de Leeuw FE, Weinstein HC, Scheltens P, Biessels GJ: Brain imaging in patients with diabetes: a systematic review. Diabetes Care 2006; 29: 2539-2548.
3. Jongen C, Biessels G: Structural brain imaging in diabetes: a methodological perspective. Eur J Pharmacol 2008; 585: 208-218.
4. Falvey CM, Rosano C, Simonsick EM, Harris T, Strotmeyer ES, Satterfield S, Yaffe K; Health ABC Study: Macro- and microstructural magnetic resonance imaging indices associated with diabetes among communitydwelling older adults. Diabetes Care 2013; 36: 677-682.
5. Moran C, Phan TG, Chen J, Blizzard L, Beare R, Venn A, Münch G, Wood AG, Forbes J, Greenaway TM, Pearson S, Srikanth V: Brain atrophy in type 2 diabetes: regional distribution and influence on cognition. Diabetes Care 2013; 36: 4036-4042.
6. Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, Liu K, Shea S, Szklo M, Bluemke DA, O'Leary DH, Tracy R, Watson K, Wong ND, Kronmal RA: Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 2008; 358: 1336-1345.
7. Folsom AR, Kronmal RA, Detrano RC, O'Leary DH, Bild DE, Bluemke DA, Budoff MJ, Liu K, Shea S, Szklo M, Tracy RP, Watson KE, Burke GL: Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the multi-ethnic study of atherosclerosis (MESA). Arch Intern Med 2008; 168: 1333-1339.
8. Agarwal S, Cox AJ, Herrington DM, Jorgensen NW, Xu J, Freedman BI, Carr JJ, Bowden DW: Coronary calcium score predicts cardiovascular mortality in diabetes: diabetes heart study. Diabetes Care 2013; 36: 972-977.
9. Raggi P, Shaw LJ, Berman DS, Callister TQ: Prognostic value of coronary artery calcium screening in subjects with and without diabetes. J Am Coll Cardiol 2004; 43: 1663-1669.
10. Polonsky TS, McClelland RL, Jorgensen NW, Bild DE, Burke GL, Guerci AD, Greenland P: Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA 2010; 303: 1610-1616.
11. Erbel R, Mohlenkamp S, Moebus S, Schmermund A, Lehmann N, Stang A, Dragano N, Gronemeyer D, Seibel R, Kalsch H, Bröcker-Preuss M, Mann K, Siegrist J, Jöckel KH; Heinz Nixdorf Recall Study Investigative Group: Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. J Am Coll Cardiol 2010; 56: 1397-1406.
12. Elias-Smale SE, Proenca RV, Koller MT, Kavousi M, van Rooij FJ, Hunink MG, Steyerberg EW, Hofman A, Oudkerk M, Witteman JC: Coronary calcium score improves classification of coronary heart disease risk in the elderly: the Rotterdam study. J Am Coll Cardiol 2010; 56: 1407-1414.
13. Hoff J, Quinn L, Sevrukov A, Lipton RB, Daviglus M, Garside DB, Ajmere NK, Gandhi S, Kondos GT: The prevalence of coronary artery calcium among diabetic individuals without known coronary artery disease. J Am Coll Cardiol 2003; 41: 1008-1012.
14. Hugenschmidt CE, Hsu FC, Hayasaka S, Carr JJ, Freedman BI, Nyenhuis DL, Williamson JD, Bowden DW: The influence of subclinical cardiovascular disease and related risk factors on cognition in type 2 diabetes mellitus: the DHS-Mind study. J Diabetes Complications 2013; 27: 422-428.
15. Bowden DW, Cox AJ, Freedman BI, Hugenschimdt CE, Wagenknecht LE, Herrington D, Agarwal S, Register TC, Maldjian JA, Ng MC, Hsu FC, Langefeld CD, Williamson JD, Carr JJ: Review of the diabetes heart study (DHS) family of studies: a comprehensively examined sample for genetic and epidemiological studies of type 2 diabetes and its complications. Rev Diabet Stud 2010; 7: 188-201.
16. Bowden DW, Lehtinen AB, Ziegler JT, Rudock ME, Xu J, Wagenknecht LE, Herrington DM, Rich SS, Freedman BI, Carr JJ, Langefeld CD: Genetic epidemiology of subclinical cardiovascular disease in the diabetes heart study. Ann Hum Genet 2008; 72(pt 5):598-610.
17. Wagenknecht LE, Bowden DW, Carr JJ, Langefeld CD, Freedman BI, Rich SS: Familial aggregation of coronary artery calcium in families with type 2 diabetes. Diabetes 2001; 50: 861-866.
18. Bowden DW, Rudock M, Ziegler J, Lehtinen AB, Xu J, Wagenknecht LE, Herrington D, Rich SS, Freedman BI, Carr JJ, Langefeld CD: Coincident linkage of type 2 diabetes, metabolic syndrome, and measures of cardiovascular disease in a genome scan of the diabetes heart study. Diabetes 2006; 55: 1985-1994.
19. Roy T, Lloyd CE, Pouwer F, Holt RI, Sartorius N: Screening tools used for measuring depression among people with type 1 and type 2 diabetes: a systematic review. Diabet Med 2012; 29: 164-175.
20. Teng EL, Chui HC: The modified mini-mental state (3MS) examination. J Clin Psychiatry 1987; 48: 314-318.
21. Wechsler D: Manual for the Wechsler Adult Intelligence Scale - Revised. New York, Psychological Corporation, 1981.
22. Houx PJ, Jolles J, Vreeling FW: Stroop interference: aging effects assessed with the Stroop Color-Word test. Exp Aging Res 1993; 19: 209-224.
23. Lezak M, Howieson D, Loring D: Neuropsychological Assessment. New York, Oxford University Press, 2004.
24. Benton AL, Hamsher KD, Sivan A: Multilingual Aphasia Examination. Iowa City, AJA Associates, 1994.
25. Strauss E, Sherman E, Spreen O: A Compendium of Neuropsychological Tests: Administration, Norms and Commentary. New York, Oxford Univeristy Press, 2006.
26. Luh WM, Wong EC, Bandettini PA, Hyde JS: QUIPSS II with thin-slice TI1 periodic saturation: a method for improving accuracy of quantitative perfusion imaging using pulsed arterial spin labeling. Magn Reson Med 1999; 41: 1246-1254.
27. Yang Y, Frank JA, Hou L, Ye FQ, McLaughlin AC, Duyn JH: Multislice imaging of quantitative cerebral perfusion with pulsed arterial spin labeling. Magn Reson Med 1998; 39: 825-832.
28. Ashburner J, Friston KJ: Voxel-based morphometry - the methods. Neuroimage 2000; 11: 805-821.
29. Jenkinson M, Beckmann CF, Behrens TE, Woolrich MW, Smith SM: FSL. NeuroImage 2012; 62: 82-90.
30. Maldjian JA, Laurienti PJ, Burdette JH, Kraft RA: Clinical implementation of spin-tag perfusion magnetic resonance imaging. J Comput Assist Tomogr 2008; 32: 403-406.
31. Johnston ME, Zheng Z, Maldjian JA, Whitlow CT, Morykwas MJ, Jung Y: Cerebral blood flow quantification in swine using pseudocontinuous arterial spin labeling. J Magn Reson Imaging 2013; 38: 1111-1118.
32. Watts JM, Whitlow CT, Maldjian JA: Clinical applications of arterial spin labeling. NMR Biomed 2013; 26: 892-900.
33. Powers WJ, Grubb RL Jr, Darriet D, Raichle ME: Cerebral blood flow and cerebral metabolic rate of oxygen requirements for cerebral function and viability in humans. J Cereb Blood Flow Metab 1985; 5: 600-608.
34. Schmidt P, Gaser C, Arsic M, Buck D, Forschler A, Berthele A, Hoshi M, Ilg R, Schmid VJ, Zimmer C, Hemmer B, Mühlau M: An automated tool for detection of FLAIRhyperintense white-matter lesions in multiple sclerosis. Neuroimage 2012; 59: 3774-3783.
35. Maldjian JA, Whitlow CT, Saha BN, Kota G, Vandergriff C, Davenport EM, Divers J, Freedman BI, Bowden DW: Automated white matter total lesion volume segmentation in diabetes. AJNR Am J Neuroradiol 2013; 34: 2265-2270.
36. Vidal JS, Sigurdsson S, Jonsdottir MK, Eiriksdottir G, Thorgeirsson G, Kjartansson O, Garcia ME, van Buchem MA, Harris TB, Gudnason V, Launer LJ: Coronary artery calcium, brain function and structure: the AGES-Reykjavik study. Stroke 2010; 41: 891-897.
37. Rosano C, Naydeck B, Kuller LH, Longstreth WT Jr, Newman AB: Coronary artery calcium: associations with brain magnetic resonance imaging abnormalities and cognitive status. J Am Geriatr Soc 2005; 53: 609-615.
38. Gianaros PJ, Greer PJ, Ryan CM, Jennings JR: Higher blood pressure predicts lower regional grey matter volume: consequences on short-term information processing. Neuroimage 2006; 31: 754-765.
39. Qiu C, Sigurdsson S, Zhang Q, Jonsdottir MK, Kjartansson O, Eiriksdottir G, Garcia ME, Harris TB, van Buchem MA, Gudnason V, Launer LJ: Diabetes, markers of brain pathology and cognitive function: the Age, Gene/Environment Susceptibility-Reykjavik study. Ann Neurol 2014; 75: 138-146.
40. Espeland MA, Bryan RN, Goveas JS, Robinson JG, Siddiqui MS, Liu S, Hogan PE, Casanova R, Coker LH, Yaffe K, Masaki K, Rossom R, Resnick SM; WHIMS-MRI Study Group: Influence of type 2 diabetes on brain volumes and changes in brain volumes: results from the Women's Health Initiative Magnetic Resonance Imaging studies. Diabetes Care 2013; 36: 90-97.
41. Schmidt R, Ropele S, Enzinger C, Petrovic K, Smith S, Schmidt H, Matthews PM, Fazekas F: White matter lesion progression, brain atrophy, and cognitive decline: the Austrian stroke prevention study. Ann Neurol 2005; 58: 610-616.
42. Reijmer YD, van den Berg E, de Bresser J, Kessels RP, Kappelle LJ, Algra A, Biessels GJ; Utrecht Diabetic Encephalopathy Study Group: Accelerated cognitive decline in patients with type 2 diabetes: MRI correlates and risk factors. Diabetes Metab Res Rev 2011; 27: 195-202.
43. Muller M, Appelman AP, van der Graaf Y, Vincken KL, Mali WP, Geerlings MI: Brain atrophy and cognition: interaction with cerebrovascular pathology? Neurobiol Aging 2011; 32: 885-893.
44. Verdelho A, Madureira S, Moleiro C, Ferro JM, Santos CO, Erkinjuntti T, Pantoni L, Fazekas F, Visser M, Waldemar G, Wallin A, Hennerici M, Inzitari D; LADIS Study: White matter changes and diabetes predict cognitive decline in the elderly: the LADIS study. Neurology 2010; 75: 160-167.
45. Madhavan KM, McQueeny T, Howe SR, Shear P, Szaflarski J: Superior longitudinal fasciculus and language functioning in healthy aging. Brain Res 2014; 1562: 11-22.
46. Laukka EJ, Lövdén M, Kalpouzos G, Li TQ, Jonsson T, Wahlund LO, Fratiglioni L, Bäckman L: Associations between white matter microstructure and cognitive performance in old and very old age. PLoS One 2013; 8: e81419.
47. Richard Jennings J, Christie IC, Muldoon MF, Ryan CM, Price JC, Meltzer CC: Brain function, cognition, and the blood pressure response to pharmacological treatment. Psychosom Med 2010; 72: 702-711.
48. Launer LJ, Miller ME, Williamson JD, Lazar RM, Gerstein HC, Murray AM, Sullivan M, Horowitz KR, Ding J, Marcovina S, Lovato LC, Lovato J, Margolis KL, O'Connor P, Lipkin EW, Hirsch J, Coker L, Maldjian J, Sunshine JL, Truwit C, Davatzikos C, Bryan RN; ACCORD MIND Investigators: Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol 2011; 10: 969-977.
49. Swan GE, DeCarli C, Miller BL, Reed T, Wolf PA, Jack LM, Carmelli D: Association of midlife blood pressure to late-life cognitive decline and brain morphology. Neurology 1998; 51: 986-993.
50. Vernooij MW, Ikram MA, Vrooman HA, Wielopolski PA, Krestin GP, Hofman A, Niessen WJ, Van der Lugt A, Breteler MM: White matter microstructural integrity and cognitive function in a general elderly population. Arch Gen Psychiatry 2009; 66: 545-553.
51. Bauer DJ, Preacher KJ, Gil KM: Conceptualizing and testing random indirect effects and moderated mediation in multilevel models: new procedures and recommendations. Psychol Methods 2006; 11: 142-163.